These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 23432363)

  • 1. Deficits in self-awareness impact the diagnosis of asymptomatic neurocognitive impairment in HIV.
    Chiao S; Rosen HJ; Nicolas K; Wendelken LA; Alcantar O; Rankin KP; Miller B; Valcour V
    AIDS Res Hum Retroviruses; 2013 Jun; 29(6):949-56. PubMed ID: 23432363
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Operationalization of the updated diagnostic algorithm for classifying HIV-related cognitive impairment and dementia.
    Foley JM; Wright MJ; Gooding AL; Ettenhofer M; Kim M; Choi M; Castellon SA; Sadek J; Heaton RK; van Gorp WG; Marcotte TD; Hinkin CH
    Int Psychogeriatr; 2011 Jun; 23(5):835-43. PubMed ID: 21092351
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Concordance Between Self-Report and Performance-Based Measures of Everyday Functioning in HIV-Associated Neurocognitive Disorders.
    Shirazi TN; Summers AC; Smith BR; Steinbach SR; Kapetanovic S; Nath A; Snow J
    AIDS Behav; 2017 Jul; 21(7):2124-2134. PubMed ID: 28108876
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuropsychological Assessment of 412 HIV-Infected Individuals in São Paulo, Brazil.
    Gascón MRP; Vidal JE; Mazzaro YM; Smid J; Marcusso RMN; Capitão CG; Coutinho EM; Benute GRG; De Lucia MCS; de Oliveira ACP
    AIDS Patient Care STDS; 2018 Jan; 32(1):1-8. PubMed ID: 29323557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alterations in the hemodynamic response function in cognitively impaired HIV/AIDS subjects.
    Juengst SB; Aizenstein HJ; Figurski J; Lopez OL; Becker JT
    J Neurosci Methods; 2007 Jul; 163(2):208-12. PubMed ID: 17540453
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurological soft signs as a marker of cognitive impairment severity in people living with HIV.
    Toro P; Ceballos ME; Pesenti J; Inostroza M; Valenzuela D; Henríquez F; Forno G; Herold C; Schröder J; Calderón J
    Psychiatry Res; 2018 Aug; 266():138-142. PubMed ID: 29870954
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determining optimal impairment rating methodology for a new HIV-associated neurocognitive disorder screening procedure.
    Kamminga J; Bloch M; Vincent T; Carberry A; Brew BJ; Cysique LA
    J Clin Exp Neuropsychol; 2017 Oct; 39(8):753-767. PubMed ID: 28052738
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Planning deficits in HIV-associated neurocognitive disorders: component processes, cognitive correlates, and implications for everyday functioning.
    Cattie JE; Doyle K; Weber E; Grant I; Woods SP;
    J Clin Exp Neuropsychol; 2012; 34(9):906-18. PubMed ID: 22731608
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Updated research nosology for HIV-associated neurocognitive disorders.
    Antinori A; Arendt G; Becker JT; Brew BJ; Byrd DA; Cherner M; Clifford DB; Cinque P; Epstein LG; Goodkin K; Gisslen M; Grant I; Heaton RK; Joseph J; Marder K; Marra CM; McArthur JC; Nunn M; Price RW; Pulliam L; Robertson KR; Sacktor N; Valcour V; Wojna VE
    Neurology; 2007 Oct; 69(18):1789-99. PubMed ID: 17914061
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnosing symptomatic HIV-associated neurocognitive disorders: self-report versus performance-based assessment of everyday functioning.
    Blackstone K; Moore DJ; Heaton RK; Franklin DR; Woods SP; Clifford DB; Collier AC; Marra CM; Gelman BB; McArthur JC; Morgello S; Simpson DM; Rivera-Mindt M; Deutsch R; Ellis RJ; Hampton Atkinson J; Grant I;
    J Int Neuropsychol Soc; 2012 Jan; 18(1):79-88. PubMed ID: 22114912
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of the sensitivity, stability, and reliability of three diagnostic schemes for HIV-associated neurocognitive disorders.
    Tierney SM; Sheppard DP; Kordovski VM; Faytell MP; Avci G; Woods SP
    J Neurovirol; 2017 Jun; 23(3):404-421. PubMed ID: 28108972
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Screening for neurocognitive impairment in HIV-positive adults aged 50 years and older: Montreal Cognitive Assessment relates to self-reported and clinician-rated everyday functioning.
    Fazeli PL; Casaletto KB; Paolillo E; Moore RC; Moore DJ; The Hnrp Group
    J Clin Exp Neuropsychol; 2017 Nov; 39(9):842-853. PubMed ID: 28122474
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neurocognitive insight and objective cognitive functioning in schizophrenia.
    Burton CZ; Harvey PD; Patterson TL; Twamley EW
    Schizophr Res; 2016 Mar; 171(1-3):131-6. PubMed ID: 26811232
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Asymptomatic neurocognitive impairment is a risk for symptomatic decline over a 3-year study period.
    Rourke SB; Bekele T; Rachlis A; Kovacs C; Brunetta J; Gill MJ; Carvalhal A; Cysique LA; Marcotte T; Power C
    AIDS; 2021 Jan; 35(1):63-72. PubMed ID: 33048883
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A preliminary evaluation of the cognitive and motor effects of pediatric HIV infection in Zairian children.
    Boivin MJ; Green SD; Davies AG; Giordani B; Mokili JK; Cutting WA
    Health Psychol; 1995 Jan; 14(1):13-21. PubMed ID: 7737068
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evolving clinical phenotypes in HIV-associated neurocognitive disorders.
    Sacktor N; Robertson K
    Curr Opin HIV AIDS; 2014 Nov; 9(6):517-20. PubMed ID: 25203640
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of performance-based measures of function in HIV-associated neurocognitive disorders.
    Gandhi NS; Skolasky RL; Peters KB; Moxley RT; Creighton J; Roosa HV; Selnes OA; McArthur J; Sacktor N
    J Neurovirol; 2011 Apr; 17(2):159-65. PubMed ID: 21437751
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Cognition disorders in HIV infection. Validation of a brief neuropsychological evaluation battery].
    Desi M; Seibel N; Korezlioglu J; Silvestre D; Linard F
    Encephale; 1995; 21(4):289-94. PubMed ID: 7588168
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A multimodal assessment of driving performance in HIV infection.
    Marcotte TD; Wolfson T; Rosenthal TJ; Heaton RK; Gonzalez R; Ellis RJ; Grant I;
    Neurology; 2004 Oct; 63(8):1417-22. PubMed ID: 15505158
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Routine detection and management of neurocognitive impairment in HIV-positive patients in a UK centre.
    Haddow LJ; Accoroni A; Cartledge JD; Manji H; Benn P; Gilson RJ
    Int J STD AIDS; 2013 Mar; 24(3):217-9. PubMed ID: 23535355
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.